Literature DB >> 9040001

D409H/D409H genotype in Gaucher-like disease.

E Uyama, M Uchino, H Ida, Y Eto, M Owada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9040001      PMCID: PMC1050881          DOI: 10.1136/jmg.34.2.175

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  10 in total

1.  Linkage of the PvuII polymorphism with the common Jewish mutation for Gaucher disease.

Authors:  A Zimran; T Gelbart; E Beutler
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

2.  1342C mutation in Gaucher's disease.

Authors:  E Beutler; C Kattamis; J Sipe; M Lipson
Journal:  Lancet       Date:  1995-12-16       Impact factor: 79.321

3.  Genotype/phenotype correlations in Gaucher's disease.

Authors:  P K Mistry
Journal:  Lancet       Date:  1995-10-14       Impact factor: 79.321

4.  Characteristics of gene mutations among 32 unrelated Japanese Gaucher disease patients: absence of the common Jewish 84GG and 1226G mutations.

Authors:  H Ida; K Iwasawa; H Kawame; O M Rennert; K Maekawa; Y Eto
Journal:  Hum Genet       Date:  1995-06       Impact factor: 4.132

5.  Tight linkage of pyruvate kinase (PKLR) and glucocerebrosidase (GBA) genes.

Authors:  D Glenn; T Gelbart; E Beutler
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

6.  Structure and organization of the human metaxin gene (MTX) and pseudogene.

Authors:  G L Long; S Winfield; K W Adolph; E I Ginns; P Bornstein
Journal:  Genomics       Date:  1996-04-15       Impact factor: 5.736

7.  Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype.

Authors:  A Abrahamov; D Elstein; V Gross-Tsur; B Farber; Y Glaser; I Hadas-Halpern; S Ronen; M Tafakjdi; M Horowitz; A Zimran
Journal:  Lancet       Date:  1995-10-14       Impact factor: 79.321

8.  Metaxin, a gene contiguous to both thrombospondin 3 and glucocerebrosidase, is required for embryonic development in the mouse: implications for Gaucher disease.

Authors:  P Bornstein; C E McKinney; M E LaMarca; S Winfield; T Shingu; S Devarayalu; H L Vos; E I Ginns
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

9.  Hydrocephalus, corneal opacities, deafness, valvular heart disease, deformed toes and leptomeningeal fibrous thickening in adult siblings: a new syndrome associated with beta-glucocerebrosidase deficiency and a mosaic population of storage cells.

Authors:  E Uyama; K Takahashi; M Owada; R Okamura; M Naito; S Tsuji; S Kawasaki; S Araki
Journal:  Acta Neurol Scand       Date:  1992-10       Impact factor: 3.209

10.  Unusual expression of Gaucher's disease: cardiovascular calcifications in three sibs homozygous for the D409H mutation.

Authors:  A Chabás; B Cormand; D Grinberg; J M Burguera; S Balcells; J L Merino; I Mate; J A Sobrino; R Gonzàlez-Duarte; L Vilageliu
Journal:  J Med Genet       Date:  1995-09       Impact factor: 6.318

  10 in total
  8 in total

1.  Gaucher disease plus.

Authors:  E Sidransky; E I Ginns
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

2.  Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.

Authors:  V Koprivica; D L Stone; J K Park; M Callahan; A Frisch; I J Cohen; N Tayebi; E Sidransky
Journal:  Am J Hum Genet       Date:  2000-05-04       Impact factor: 11.025

3.  Recurrence of the D409H mutation in Spanish Gaucher disease patients: description of a new homozygous patient and haplotype analysis.

Authors:  A Chabás; L Gort; M Montfort; F Castelló; M C Domínguez; D Grinberg; L Vilageliu
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

4.  Clinical and molecular characteristics of Japanese Gaucher disease.

Authors:  Y Eto; H Ida
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

Review 5.  Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes.

Authors:  Emily C Daykin; Emory Ryan; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2021-01-09       Impact factor: 4.797

6.  Aortic calcification in Gaucher disease: a case report.

Authors:  Saud Alsahli; Dalal K Bubshait; Zuhair A Rahbeeni; Majid Alfadhel
Journal:  Appl Clin Genet       Date:  2018-10-17

7.  Cardiac Manifestations in a Group of Romanian Patients with Gaucher Disease Type 1 (a Monocentric Study).

Authors:  Cecilia Lazea; Simona Bucerzan; Camelia Al-Khzouz; Anca Zimmermann; Ștefan Cristian Vesa; Ioana Nașcu; Victoria Creț; Mirela Crișan; Carmen Asăvoaie; Diana Miclea; Paula Grigorescu-Sido
Journal:  Diagnostics (Basel)       Date:  2021-05-29

Review 8.  Imiglucerase in the treatment of Gaucher disease: a history and perspective.

Authors:  Patrick B Deegan; Timothy M Cox
Journal:  Drug Des Devel Ther       Date:  2012-04-18       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.